Advances in minimally invasive treatment of benign and malignant prostate disease

Coordinator(s)

• EW

  Eric Walser, MD (he/him/his)

  Professor and Chairman of Radiology
  UTMB

  Disclosure(s): No financial relationships to disclose
• 

  David Woodrum, M.D., Ph.D

  Professor of Interventional Radiology
  Mayo Clinic

  Disclosure(s): ABBOTT, ANGIODYNAMICS, BD BARD, BOSTON SCIENTIFIC, CSI, GORE, MEDTRONIC, PHILIPS: Consultant (Ongoing)

Interventional radiologists can address prostate cancer and symptomatic benign prostatic hypertrophy (BPH) using transperineal and transrectal techniques and different ablation energy sources (cryoablation, laser, microwave, and focused ultrasound). This session reviews these methods and evaluates the safety and efficacy of IR in the prostate gland as well as MRI imaging necessary to evaluate the prostate gland before and after ablation procedures. IR techniques are also discussed in the context of current urologic methods to treat both BPH and prostate cancer

Presentations:

• 8:30 AM – 8:43 AM

  Transurethral ultrasound ablation (TULSA) --a new non-invasive technique for treating prostate disease.
  

  Speaker: David Sella, MD – Mayo Clinic Florida
• 8:43 AM – 8:56 AM

  Image guided ablation of recurrent prostate cancer
  

  Speaker: David Woodrum, M.D., Ph.D – Mayo Clinic
• 8:56 AM – 9:09 AM

  Post treatment MRI imaging of the prostate gland
  

  Speaker: Steven Raman, MD, FSAR, FSIR – David Geffen School of Medicine At UCLA
• 9:09 AM – 9:22 AM

  CT guided procedures in the prostate gland
  

  Speaker: Vijay Ramalingam, MD – Beth Israel Deaconess Medical Center
• 9:22 AM – 9:35 AM

  The urologist's perspective of prostate ablation procedures
  

  Speaker: Lance A. Mynderse, MD, MS – Mayo Clinic
• 9:35 AM – 9:48 AM

  Transperineal ultrasound guided laser ablation (TPLA) for benign and malignant prostate disease
  

  Speaker: Eric M. Walser, MD (he/him/his) – UTMB
• 9:48 AM – 10:00 AM

  Q & A